Home » Topics » BioWorld

BioWorld
RSS

IMNX MOVES UP ON $900 MILLION VALUATION

April 28, 1992

CYGNUS NICOTINE PATCH APPROVED FOR MARKET

April 28, 1992

MCLAUCHLAN SUCCEEDS SCHEIN AS UBS PRESIDENT

April 28, 1992

START-UP TO USE DISEASED CELLS TO LOCATE DRUGS

April 28, 1992

EPITOPE MOVES ON EPIBLOT, ORASURE

April 28, 1992

CYTEL GRANT FOR CHRONIC HEPATITIS VACCINE

April 28, 1992

BRITISH-BIO FILES SILENT IPO

April 28, 1992

IMPENDING FDA-CENTOCOR DEAL REPORTED

April 28, 1992

PCR OUTPERFORMS HEPATITIS C ASSAYS

April 27, 1992

GENE DELIVERY CROSS-LICENSING

April 27, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...